Search

Ocugen Inc

Cerrado

1.36 0.74

Resumen

Variación precio

24h

Actual

Mínimo

1.35

Máximo

1.43

Métricas clave

By Trading Economics

Ingresos

-1.5M

-19M

Ventas

1.7M

1.5M

BPA

-0.06

Margen de beneficios

-1,250.946

Empleados

116

EBITDA

-987K

-17M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+576.22% upside

Dividendos

By Acuity

Próximas Ganancias

31 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-149M

477M

Apertura anterior

0.62

Cierre anterior

1.36

Ocugen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 jul 2026, 23:56 UTC

Intel Corp shares are lower in after-hours trading, reflecting broader market pressures amid a significant decline in Japan's Nikkei 225 Index.

16 jul 2026, 23:56 UTC

ETF Constituents
Macro News

iShares China Large-Cap ETF trades lower in after-market hours amid rising U.S.-Iran tensions and weakness in technology stocks, with notable declines from TCOM and LI.

16 jul 2026, 23:56 UTC

ETF Constituents
Macro News
Correlated Moves

The iShares MSCI Japan ETF is lower in after-market trading, reflecting declines in the Nikkei 225 index and key holdings like SONY and NMR.

16 jul 2026, 23:52 UTC

Fed Vice Chair Jefferson signals potential interest rate reassessment amid persistent inflation concerns.

16 jul 2026, 23:52 UTC

Michigan Consumer Sentiment Index for July 2026 Forecasted at 51.0 Amid Mixed Confidence and Inflation Concerns Ahead of Release.

16 jul 2026, 23:52 UTC

Social Media
News

Netflix Inc. shares fell in after-hours trading following Q2 results. Revenue of $12.56 billion missed expectations, and guidance for 2026 was narrowed lower.

16 jul 2026, 23:52 UTC

Social Media
Correlated Moves

NVIDIA Corp shares declined in after-market hours, reflecting broader market downturn and geopolitical tensions. The stock underperformed against major tech peers during the session.

16 jul 2026, 23:51 UTC

Global equity markets decline as Nikkei 225 drops 2.8%, while U.S. jobless claims fall unexpectedly and manufacturing activity surges, amid concerns over slowing retail sales and geopolitical tensions.

16 jul 2026, 23:51 UTC

Mixed trading in European equities amid geopolitical tensions and mixed earnings; U.S. tech stocks decline as jobless claims fall unexpectedly.

16 jul 2026, 23:51 UTC

U.S. equity markets remain flat amid geopolitical tensions and mixed economic data, with Nasdaq down 1.5% as oil prices surge above $80 per barrel.

16 jul 2026, 23:51 UTC

Asia equity markets mixed as Japan's Nikkei drops 2.8% on tech weakness, while GBP/USD falls amid geopolitical tensions and U.S. tech stocks face pressure from disappointing earnings.

16 jul 2026, 23:46 UTC

Social Media

Shares of Electronic Arts Inc are lower in after-market trading, reflecting a decline from earlier gains. Upcoming EA SPORTS FC 27 release is drawing attention.

16 jul 2026, 23:46 UTC

News

Paychex declared a quarterly dividend of $1.19 per share, payable August 28, contributing to positive sentiment as shares rise in after-market trading.

16 jul 2026, 23:46 UTC

Cintas Corp shares are higher in after-market hours. Broader market sentiment may be supported by recent labor market strength and modest retail sales growth.

16 jul 2026, 23:46 UTC

ETF Constituents
News
Correlated Moves

Vanguard Growth ETF declines after-hours, impacted by Netflix's drop and broader Nasdaq 100 downturn amid rising inflation concerns and central bank comments.

16 jul 2026, 23:46 UTC

American Airlines Group Inc. shares are lower in after-market trading, reflecting routine fluctuations and remaining below the 20-day moving average.

16 jul 2026, 23:42 UTC

Cisco shares traded higher during after-market hours, reflecting internal dynamics. The stock's activity remained routine amid broader declines in major technology stocks.

16 jul 2026, 23:41 UTC

Gilead Sciences Inc. shares moved higher in after-market trading, remaining above their 20-day moving average following three consecutive daily gains.

16 jul 2026, 23:41 UTC

Lululemon shares declined in after-market trading, continuing a downward trend since Thursday's close amid weakness in major technology stocks.

16 jul 2026, 23:41 UTC

News
Correlated Moves

Lam Research Corp shares are lower in after-market trading amid a sector-wide selloff following TSMC's capital expenditure announcement and bearish sentiment from options traders.

16 jul 2026, 23:41 UTC

Correlated Moves

KLA Corp shares are lower in after-market hours, reflecting broader market declines amid weakness in major technology stocks and renewed semiconductor sector volatility.

16 jul 2026, 23:41 UTC

ETF Constituents
Macro News
Correlated Moves

Financial Select Sector SPDR Fund trades lower in after-market hours amid broader market decline and rising tensions between the U.S. and Iran.

16 jul 2026, 23:41 UTC

Trip.com Group Ltd shares are lower in after-market hours amid broader market declines, particularly in technology stocks and heightened economic uncertainty.

16 jul 2026, 23:41 UTC

Baidu Inc. shares are trading lower in after-market hours, reflecting broader market declines amid volatility in the semiconductor sector and geopolitical tensions.

16 jul 2026, 23:41 UTC

JD.Com Inc. shares are higher in after-market trading, supported by gains in the Broadline Retail sub-sector. The stock remains above its 20-day moving average.

16 jul 2026, 23:41 UTC

Correlated Moves

Analog Devices Inc remains unchanged in after-market trading amid declines in the Nasdaq 100 Index and weakness among major technology stocks.

16 jul 2026, 23:41 UTC

Macro News
Correlated Moves

Ethereum is trading lower as U.S. markets decline amid technology sector weakness and rising geopolitical tensions, impacting global sentiment in cryptocurrencies.

16 jul 2026, 23:41 UTC

Macro News
Correlated Moves

Bitcoin declines amid rising U.S.-Iran tensions and market volatility. The Crypto Fear & Greed Index shows extreme fear among investors, contributing to uncertainty.

16 jul 2026, 23:41 UTC

Booking Holdings Inc. shares are higher in after-market trading, maintaining levels above the 20-day moving average amid slight fluctuations since Thursday's close.

16 jul 2026, 23:36 UTC

Ross Stores Inc. shares declined in after-market trading amid weakness in major technology stocks. The asset is lower since Thursday's close.

Comparación entre iguales

Cambio de precio

Ocugen Inc previsión

Precio Objetivo

By TipRanks

576.22% repunte

Estimación a 12 Meses

Media 9.67 USD  576.22%

Máximo 12 USD

Mínimo 7 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocugen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat